Defective activity of monocytes from patients with non- Hodgkin lymphoma: The modulatory effect of granulocyte- macrophage-colony stimulating factor

Cancer

Volumn 86, Issue 10, 1999, Pages 2133-2137

  Burgaleta, Carmen ^a,b   Villalba, Sonia ^a   González, Nuria ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

Granulocyte macrophage colony stimulating factor; Lymphoma; Monocyte defects; Monocytes

Indexed keywords

RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CHEMOTAXIS; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HOST RESISTANCE; HUMAN; IMMUNOTHERAPY; INFECTION RESISTANCE; LEUKOCYTE MIGRATION; MALE; NONHODGKIN LYMPHOMA; PHAGOCYTOSIS; PRIORITY JOURNAL;

ADULT; AGED; CANDIDA ALBICANS; CASE-CONTROL STUDIES; CHEMOTAXIS; FEMALE; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MONOCYTES; PHAGOCYTOSIS;

EID: 0033570964     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991115)86:10<2133::AID-CNCR35>3.0.CO;2-C     Document Type: Article

References (29)

1. Cline MJ. Defective mononuclear phagocyte function in patients with myelomonocytic leukemia and in some patients with lymphoma. J Clin Invest 1973;52:2185-90.
2. Ward PA, Berenberg JL. Defective regulation of inflammatory mediators in Hodgkin's disease. N Engl J Med 1974;290: 76-80.
3. Gadish M, Kletter Y, Flidel O, Nagler A, Slavin S, Fabian I. Effects of recombinant human granulocyte and granulocyte-macrophage colony-stimulating factors on neutrophil function following allogenic bone marrow transplantation. Leuk Res 1991;15:1175-82.
4. Unger SW, Bernhard MI, Pace RC, Wanebo HJ. Monocyte dysfunction in human cancer. Cancer 1983;15:669-74.
5. Cantrell MA, Anderson D, Cerretti DP, Price V, McKereghan K, Tushinski RJ, et al. Cloning, sequence, and expression of a human granulocyte/macrophage colony-stimulating factor. Proc Natl Acad Sci USA 1985;82:6250-4.
6. Metcalf D, Begley CG, Johnson GR, Nicola NA, Vadas MA, Lopez AE, et al. Biologic properties in vitro of a recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1986;67:37-45.
7. Neidhart JA. Hematopoietic colony-stimulating factors. Uses in combination with standard chemotherapeutic regimens and in support of dose intensification. Cancer 1992; 70:913-20.
8. Pettengell R, Gurney H, Radford JA, Deakin DP, James R, Wilkinson PM, et al. GM-CSF to prevent dose-limiting neutropenia in non Hodgkin's lymphoma. A randomized controlled trial. Blood 1992;80:1430-6.
9. Morstyn G, Lieschke GJ, Sheridan W, Layton J, Cebon J, Fox RM, Clinical experience with recombinant human granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Semin Hematol 1989;26:9-13.
10. Ho AD, Haas R, Korbling M, Dietz M, Hunstein W. Utilization of rhGM-CSF to enhance peripheral progenitor cell yield for autologous transplantation. Bone Marrow Transpl 1991;7:13-7.
11. O'Day SJ, Rabinoue SN, Neuberg D, Freedman A, Soiffer RJ, Spector NA, et al. A Phase II study of continuous infusion recombinant as an adjunct to autologous bone marrow transplantation for patient with non-Hodgkin lymphoma in first remission. Blood 1994;83:2707-14.
12. Ruef C, Coleman DL. Granulocyte-macrophage colonystimulating factor: pleiotropic cytokine with potential clinical usefulness. Rev Infect Dis 1990;12:41-62.
13. Bodey GP, Anaissie E, Gutterman J, Vadhan-Raj S. Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer. Clin Infect Dis 1993;17:705-7.
14. -2 production. J Cell Physiol 1989;139:361-9.
15. Yong K, Addison IE, Johnson B, Webster AD, Linch DC. Role of leukocyte integrins in phagocytic responses to granulocyte-macrophage colony stimulating factor (GM-CSF) in vitro and in vivo studies on leukocyte adhesion deficiency neutrophils. Br J Hematol 1991;77:150-7.
16. Fleischmann J, Golde DW, Weisbart RH, Gasson JC. Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils. Blood 1986; 68:708-11.
17. Vadas MA, Nicola NA, Metcalf D. Activation of antibodydependent cell-mediated cytotoxicity of human neutrophils and eosinophils by separate colony-stimulating factors. J Inmunol 1983;130:795-9.
18. Ho A, Rainer H, Wulf G, Knauf W, Ehrhardt R, Heilig B, et al. Activation of lymphocytes induced by recombinant human granulocyte-macrophage colony-stimulating factor in patients with malignant lymphoma. Blood 1990;72:203-12.
19. Roilides E, Holmes A, Blake C, Venzon D, Pizzo PA, Walsh TJ. Antifungal activity of eluited human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocytemacrophage colony-stimulating factor and interferongamma. J Infect Dis 1994;170:894-9.
20. Lehrer RI. The fungicidal activity of human leukocytes. In: Williams RC, Funderberg MH, editors. Phagocytic mechanisms in health and disease. New York: Intercontinental Medical Co., 1972:151-65.
21. Boyden S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes. J Exp Med 1962;115:971-5.
22. King GW, LoBuglio AF. Human phagocyte glucose metabolism in lymphoma. J Lab Clin Med 1977;89:318-22.
23. Donald P, Braun PD, Jules E. Harris. Abnormal monocyte function in patients with Kaposi's sarcoma. Cancer 1986;57: 1501-6.
24. Coleman DL, Chodakewitz JA, Bartiss AH, Mellors JW. Granulocyte-macrophage colony-stimulating factor enhances selective effector functions of tissue-derived macrophages. Blood 1988;72:573-8.
25. Levits SM. Activation of human peripheral blood mononuclear cells by IL2 and GM-CSF to inhibit Cryptococcus neoformans. Infect Immunol 1991;59:3393-7.
26. Kharazmi A, Nielsen H, Bendtzeen K. Modulation of neutrophil and monocyte chemotaxis and superoxide response by recombinant TNF-alpha and GM-CSF. Immunobiology 1988;69:18-21.
27. Sullivan GW, Carper HT, Mandell G. The effect of human recombinant hematopoietic growth factors (granulocytemacrophage colony-stimulating factor, granulocyte colonystimulating factor and interleukin-3) on phagocyte oxidative metabolism. Blood 1993;81:1863-70.
28. Smith PD, Lamerson CL, Banks SM, Saini SS, Wahl LM, Calderone RA, et al. Granulocyte-macrophage colonystimulating factor augments human monocyte fungicidal activity for Candida albicans. J Infect Dis 1990;161:999-05.
29. Bermudez LE, Kemper CA, Dereniski SC. Disfunctional monocytes from a patient with disseminated Mycobacterium Kansasii infection are activated in vitro and in vivo by GM-CSF. Biotherapy 1994;8:135-42.